🇺🇸 FDA
Patent

US 8092838

Use of hydrogen sulfide in the treatment of eye diseases

granted A61KA61K33/04A61P

Quick answer

US patent 8092838 (Use of hydrogen sulfide in the treatment of eye diseases) held by BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA expires Mon Jan 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA
Grant date
Tue Jan 10 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K33/04, A61P, A61P27/02